Apellis Pharmaceuticals Stock Price - APLS

-0.25 (-0.99%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Apellis Pharmaceuticals Inc APLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.88 -3.37% 25.25 24.88 26.40 25.75 26.13 18:15:56
Bid Price Ask Price Spread Spread % News
24.38 25.31 0.93 3.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,950 400,715 $ 25.36 $ 10,163,635 1,080,175 16.85 - 50.00
Last Trade Time Type Quantity Stock Price Currency
18:15:56 36 $ 25.00 USD

Apellis Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.90B 75.32M $ -127.50M -5.20 - 71.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 39.00 5.00%

more financials information »

Apellis Pharmaceuticals News

Loading Messages....

Latest APLS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APLS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week26.2029.6624.343526.42655,501-0.95-3.63%
1 Month32.5734.8016.8525.241,109,431-7.32-22.47%
3 Months38.2345.0416.8534.221,014,164-12.98-33.95%
6 Months24.2050.0016.8533.711,243,1171.054.34%
1 Year20.4050.0016.8531.61819,0614.8523.77%
3 Years14.5050.0011.4527.52503,12410.7574.14%
5 Years14.5050.0011.4527.52503,12410.7574.14%

Apellis Pharmaceuticals Description

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Your Recent History
Apellis Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.